At Glenmark, I scaled the dermatology P&L from ₹80 Cr to ₹180 Cr, grew market share from 6.15% to 8.9%, and repositioned the portfolio from #4 to #2 in CVM rankings. Syntran SB, Aprezo, and Scalpe+ achieved #1 prescription leadership, and I launched India's first AI-enabled dermatology patient-education chatbot in partnership with IADVL.
Across commercial and business development roles in pharmaceuticals and process systems, I've turned around underperforming portfolios, developed product pipelines, and supported growth through strategic planning and new launches. My experience includes dermatology, gastroenterology, critical care, respiratory, oncology, hormonal, biotechnology, and ophthalmic products; I completed the Senior Management Program at IIM Ahmedabad and studied AI in Healthcare through Stanford Online.

